Tatva Chintan exports its merchandise to greater than 25 nations, together with USA, China and Germany
Tatva Chintan Pharma Chem, a specialty chemical manufacturing firm, has filed preliminary papers with the market regulator Sebi for an preliminary public providing (IPO). The IPO will comprise a contemporary challenge of shares price Rs 225 crore and a proposal of sale amounting to Rs 225 crore by present promoters and shareholders, in line with the corporate’s draft pink herring prospectus.
Tatva Chintan Pharma Chem will use the IPO proceeds to fund its capital expenditure necessities, develop the Dahej manufacturing facility and for common company functions.
Based in Vadodara, Tatva Chintan exports its merchandise to greater than 25 nations, together with the USA, China, Germany, Japan, South Africa and the UK.
ICICI Securities and JM Financials are the service provider bankers to the difficulty of Tatva Chintan Pharma.
